Charles G Drake

15PUBLICATIONS
139CO-AUTHORS
Molecular targetsInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Electrical energy transmission, networks and systemsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Mar 12, 2026
Molecular Characterization of KLK2 RNA Expression in Prostate Cancer.

Rana R McKay, Shayan S Nazari, Andrew Elliott

|Jul 08, 2025
Human Kallikrein 2: A Novel Lineage-Specific Surface Target in Prostate Cancer.

Fei Shen, Ryan Smith, Theresa McDevitt

|Dec 09, 2024
Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer.

Lisa N Chesner, Fanny Polesso, Julie N Graff

|Sep 24, 2024
Fc-enhanced anti-CTLA-4 depletes tumor-infiltrating regulatory T cells to augment immune effects of androgen ablation in high-risk prostate cancer.

Casey R Ager, Aleksandar Obradovic, Patrick McCann

|Sep 13, 2024
Androgen Deprivation Therapy Drives a Distinct Immune Phenotype in Localized Prostate Cancer.

Matthew C Dallos, Aleksandar Z Obradovic, Patrick McCann

|Jul 02, 2024
High-dimensional mapping of human CEACAM1 expression on immune cells and association with melanoma drug resistance.

Yu-Hwa Huang, Charles H Yoon, Amit Gandhi

Pageof 3

Frequent Collaborators

3 joint publications

Aleksandar Z Obradovic

3 joint publications

Emmanuel S Antonarakis

2 joint publications

Lawrence Fong

2 joint publications

Matthew C Dallos